Healthcare industry players make payments to medical providers for non-research expenses. While these payments may pose conflicts of interest, their relationship with overall healthcare costs remains largely unknown. In this study, we linked Open Payments data on providers’ industry payments with Medicare data on healthcare costs. We investigated 374,766 providers’ industry payments and healthcare costs. We demonstrate that providers receiving higher amounts of industry payments tend to bill higher drug and medical costs. Specifically, we find that a 10% increase in industry payments is associated with 1.3% higher medical and 1.8% higher drug costs. For a typical provider, for example, a 10% or 25 increase in annual industry payments would ...
The interaction of disclosure laws and the targeted behavior is typically unknown since data on disc...
BackgroundThe rapidly increased spending on insulin is a major public health issue in the United Sta...
We use insurance claims data for 27.6 percent of individuals with private employer-sponsored insuran...
Abstract Background While many new medications may offer advantages over existing drugs, some newer ...
The U.S. Physician Payments Sunshine Act mandates the reporting of payments or items of value receiv...
Physician-industry interactions are common, and the nature of industry payment to physicians and the...
BACKGROUND:While the rise in opioid analgesic prescribing and overdose deaths was multifactorial, fi...
BackgroundMany oncologists who lead guidelines and clinical trials have financial conflicts of inter...
BackgroundA study has shown that industry payments to physicians for drugs are associated not only w...
Pharmaceutical scandals frequently occupy national media headlines, and these controversial practice...
This paper estimates the impact of gifts - monetary or in-kind payments - from pharmaceutical firms ...
The study explores price transparency in the healthcare system. With the increase in healthcare spen...
The cost of bargaining and billing leads private players, usually much smaller, to use Medicare's mo...
Transparency has become one of the primary themes in health care reform efforts in the United States...
<div><p>Background</p><p>In 2013 the United States spent $2.9 trillion on health care, more than in ...
The interaction of disclosure laws and the targeted behavior is typically unknown since data on disc...
BackgroundThe rapidly increased spending on insulin is a major public health issue in the United Sta...
We use insurance claims data for 27.6 percent of individuals with private employer-sponsored insuran...
Abstract Background While many new medications may offer advantages over existing drugs, some newer ...
The U.S. Physician Payments Sunshine Act mandates the reporting of payments or items of value receiv...
Physician-industry interactions are common, and the nature of industry payment to physicians and the...
BACKGROUND:While the rise in opioid analgesic prescribing and overdose deaths was multifactorial, fi...
BackgroundMany oncologists who lead guidelines and clinical trials have financial conflicts of inter...
BackgroundA study has shown that industry payments to physicians for drugs are associated not only w...
Pharmaceutical scandals frequently occupy national media headlines, and these controversial practice...
This paper estimates the impact of gifts - monetary or in-kind payments - from pharmaceutical firms ...
The study explores price transparency in the healthcare system. With the increase in healthcare spen...
The cost of bargaining and billing leads private players, usually much smaller, to use Medicare's mo...
Transparency has become one of the primary themes in health care reform efforts in the United States...
<div><p>Background</p><p>In 2013 the United States spent $2.9 trillion on health care, more than in ...
The interaction of disclosure laws and the targeted behavior is typically unknown since data on disc...
BackgroundThe rapidly increased spending on insulin is a major public health issue in the United Sta...
We use insurance claims data for 27.6 percent of individuals with private employer-sponsored insuran...